Macrovascular Disease in the Elderly with Type 1 DiabetesChapman MJ1, Crockett SC1, Purvis TE1, Anderson MJ1, Whittaker PL1, Bhattacharjee R1, Marshall TP2, Narendran P1 and Nirantharakumar K2,3*
- *Corresponding Author:
- Nirantharakumar K
Senior Research Fellow
Institute of Digital Healthcare
WMG, University of Warwick
Coventry, CV4 7AL, UK
E-mail: [email protected]
Received date: July 31, 2013; Accepted date: September 25, 2013; Published date: September 30, 2013
Citation: Chapman MJ, Crockett SC, Purvis TE, Anderson MJ, Whittaker PL, et al. (2013) Macrovascular Disease in the Elderly with Type 1 Diabetes. J Diabetes Metab 4:299. doi:10.4172/2155-6156.1000299
Copyright: © 2013 Chapman MJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Macrovascular disease (MVD) is a major complication of type 1 diabetes mellitus. However, accurate data on the prevalence and impact of macrovascular disease in the elderly with type 1 diabetes is lacking. This is despite life expectancy increasing in this population. Using data from over 400 general practices in the UK, the prevalence of macrovascular disease and factors associated with it were identified in elderly (over 65years) patients with type 1 diabetes for the year 2008.In this population, there was high prevalence of macrovascular disease(39.5%). Patients with macrovascular disease were significantly older, had a longer duration of diabetes, a positive history of smoking and higher HbA1cvalues. Our analysis demonstrates a high burden of macrovascular disease in elderly patients with type 1 diabetes. We need to explore how best to address this disease in this population.